|
1
|
Spruit MA, Janssen PP, Willemsen SC,
Hochstenbag MM and Wouters EF: Exercise capacity before and after
an 8-week multidisciplinary inpatient rehabilitation program in
lung cancer patients: A pilot study. Lung Cancer. 52:257–260. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Inamura K, Fujiwara T, Hoshida Y, Isagawa
T, Jones MH, Virtanen C, Shimane M, Satoh Y, Okumura S, Nakagawa K,
et al: Two subclasses of lung squamous cell carcinoma with
different gene expression profiles and prognosis identified by
hierarchical clustering and non-negative matrix factorization.
Oncogene. 24:7105–7113. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Ferlay J, Steliarova-Foucher E,
Lortet-Tieulent J, Rosso S, Coebergh JW, Comber H, Forman D and
Bray F: Cancer incidence and mortality patterns in Europe:
Estimates for 40 countries in 2012. Eur J Cancer. 49:1374–1403.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Chang S, Dai M, Ren JS, Chen YH and Guo
LW: Estimates and prediction on incidence, mortality and prevalence
of lung cancer in China in 2008. Zhonghua Liu Xing Bing Xue Za Zhi.
33:391–394. 2012.In Chinese. PubMed/NCBI
|
|
5
|
Li S, Huang S and Peng SB: Overexpression
of G protein-coupled receptors in cancer cells: Involvement in
tumor progression. Int J Oncol. 27:1329–1339. 2005.PubMed/NCBI
|
|
6
|
Raponi M, Zhang Y, Yu J, Chen G, Lee G,
Taylor JM, Macdonald J, Thomas D, Moskaluk C, Wang Y and Beer DG:
Gene expression signatures for predicting prognosis of squamous
cell and adenocarcinomas of the lung. Cancer Res. 66:7466–7472.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Sanchez-Palencia A, Gomez-Morales M,
Gomez-Capilla JA, Pedraza V, Boyero L, Rosell R and Fárez-Vidal ME:
Gene expression profiling reveals novel biomarkers in nonsmall cell
lung cancer. Int J Cancer. 129:355–364. 2011. View Article : Google Scholar
|
|
8
|
Navab R, Strumpf D, Bandarchi B, Zhu CQ,
Pintilie M, Ramnarine VR, Ibrahimov E, Radulovich N, Leung L,
Barczyk M, et al: Prognostic gene-expression signature of
carcinoma-associated fibroblasts in non-small cell lung cancer.
Proc Natl Acad Sci USA. 108:7160–7165. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Tsuta K, Tanabe Y, Yoshida A, Takahashi F,
Maeshima AM, Asamura H and Tsuda H: Utility of 10
immunohistochemical markers including novel markers (desmocollin-3,
glypican 3, S100A2, S100A7, and Sox-2) for differential diagnosis
of squamous cell carcinoma from adenocarcinoma of the Lung. J
Thorac Oncol. 6:1190–1199. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Hamamoto J, Soejima K, Yoda S, Naoki K,
Nakayama S, Satomi R, Terai H, Ikemura S, Sato T, Yasuda H, et al:
Identification of microRNAs differentially expressed between lung
squamous cell carcinoma and lung adenocarcinoma. Mol Med Rep.
8:456–462. 2013.PubMed/NCBI
|
|
11
|
Liu J, Yang XY and Shi WJ: Identifying
differentially expressed genes and pathways in two types of
non-small cell lung cancer: Adenocarcinoma and squamous cell
carcinoma. Genet Mol Res. 13:95–102. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Haynes W: Benjamini-Hochberg method.
Encyclopedia of Systems Biology. Dubitzky W, Wolkenhauer O, Cho KH
and Yokota H: Springer; New York, NY: pp. 782013, View Article : Google Scholar
|
|
13
|
Huang da W, Sherman BT and Lempicki RA:
Bioinformatics enrichment tools: Paths toward the comprehensive
functional analysis of large gene lists. Nucleic Acids Res.
37:1–13. 2009. View Article : Google Scholar
|
|
14
|
Huang da W, Sherman BT and Lempicki RA:
Systematic and integrative analysis of large gene lists using DAVID
bioinformatics resources. Nat Protoc. 4:44–57. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Peri S, Navarro JD, Amanchy R, Kristiansen
TZ, Jonnalagadda CK, Surendranath V, Niranjan V, Muthusamy B,
Gandhi TK, Gronborg M, et al: Development of human protein
reference database as an initial platform for approaching systems
biology in humans. Genome Res. 13:2363–2371. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Semënov MV and Snyder M: Human dishevelled
genes constitute a DHR-containing multigene family. Genomics.
42:302–310. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Wei Q, Zhao Y, Yang ZQ, Dong QZ, Dong XJ,
Han Y, Zhao C and Wang EH: Dishevelled family proteins are
expressed in non-small cell lung cancer and function differentially
on tumor progression. Lung Cancer. 62:181–192. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Wang J, Qian J, Hoeksema MD, Zou Y,
Espinosa AV, Rahman SM, Zhang B and Massion PP: Integrative
genomics analysis identifies candidate drivers at 3q26-29 amplicon
in squamous cell carcinoma of the lung. Clin Cancer Res.
19:5580–5590. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Gao Q, Yang S and Kang MQ: Influence of
survivin and Bcl-2 expression on the biological behavior of
non-small cell lung cancer. Mol Med Rep. 5:1409–1414.
2012.PubMed/NCBI
|
|
20
|
Han ZX, Wang HM, Jiang G, Du XP, Gao XY
and Pei DS: Overcoming paclitaxel resistance in lung cancer cells
via dual inhibition of stathmin and Bcl-2. Cancer Biother
Radiopharm. 28:398–405. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Zhang J, Wang S, Wang L, Wang R, Chen S,
Pan B, Sun Y and Chen H: Prognostic value of Bcl-2 expression in
patients with non-small-cell lung cancer: A meta-analysis and
systemic review. Onco Targets Ther. 8:3361–3369. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Zhao XD, He YY, Gao J, Zhao C, Zhang LL,
Tian JY and Chen HL: High expression of Bcl-2 protein predicts
favorable outcome in non-small cell lung cancer: Evidence from a
systematic review and meta-analysis. Asian Pac J Cancer Prev.
15:8861–8869. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Gallegos Ruiz MI, Floor K, Roepman P,
Rodriguez JA, Meijer GA, Mooi WJ, Jassem E, Niklinski J, Muley T,
van Zandwijk N, et al: Integration of gene dosage and gene
expression in non-small cell lung cancer, identification of HSP90
as potential target. PLoS One. 3:e00017222008. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Workman P, Burrows F, Neckers L and Rosen
N: Drugging the cancer chaperone HSP90: Combinatorial therapeutic
exploitation of oncogene addiction and tumor stress. Ann NY Acad
Sci. 1113:202–216. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Sequist LV, Gettinger S, Senzer NN,
Martins RG, Jänne PA, Lilenbaum R, Gray JE, Iafrate AJ, Katayama R,
Hafeez N, et al: Activity of IPI-504, a novel heat-shock protein 90
inhibitor, in patients with molecularly defined non-small-cell lung
cancer. J Clin Oncol. 28:4953–4960. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Li G, Qiu Y, Su Z, Ren S, Liu C, Tian Y
and Liu Y: Genome-wide analyses of radioresistance-associated miRNA
expression profile in nasopharyngeal carcinoma using next
generation deep sequencing. PLoS One. 8:e844862013. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Hu S, Danilov AV, Godek K, Orr B, Tafe LJ,
Rodriguez-Canales J, Behrens C, Mino B, Moran CA, Memoli VA, et al:
CDK2 inhibition causes anaphase catastrophe in lung cancer through
the centrosomal protein CP110. Cancer Res. 75:2029–2038. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Abrams TJ, Lee LB, Murray LJ, Pryer NK and
Cherrington JM: SU11248 inhibits KIT and platelet-derived growth
factor receptor beta in preclinical models of human small cell lung
cancer. Mol Cancer Ther. 2:471–478. 2003.PubMed/NCBI
|
|
29
|
Geng L, Cuneo KC, Fu A, Tu T, Atadja PW
and Hallahan DE: Histone deacetylase (HDAC) inhibitor LBH589
increases duration of gamma-H2AX foci and confines HDAC4 to the
cytoplasm in irradiated non-small cell lung cancer. Cancer Res.
66:11298–11304. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Platta CS, Greenblatt DY, Kunnimalaiyaan M
and Chen H: The HDAC inhibitor trichostatin A inhibits growth of
small cell lung cancer cells. J Surg Res. 142:219–226. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Komatsu N, Kawamata N, Takeuchi S, Yin D,
Chien W, Miller CW and Koeffler HP: SAHA, a HDAC inhibitor, has
profound anti-growth activity against non-small cell lung cancer
cells. Oncol Rep. 15:187–191. 2006.
|
